Detalhe da pesquisa
1.
Disease activity-guided dose optimisation including discontinuation of TNF-inhibitors in rheumatoid arthritis is effective for up to 10 years: an observational follow-up of the DRESS study.
Rheumatology (Oxford)
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38346712
2.
An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists.
Rheumatology (Oxford)
; 62(8): 2797-2805, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36637182
3.
18F-FDG PET-CT in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value.
Rheumatology (Oxford)
; 61(SI): SI6-SI13, 2022 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791068
4.
The value of incorporating patient-consulted medication reconciliation in influencing drug-related actions in the outpatient rheumatology setting.
BMC Health Serv Res
; 22(1): 995, 2022 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35927690
5.
Polymyalgia rheumatica patients with and without elevated baseline acute phase reactants: distinct subgroups of polymyalgia rheumatica?
Clin Exp Rheumatol
; 39(1): 32-37, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242804
6.
Effect of add-on methotrexate in polymyalgia rheumatica patients flaring on glucocorticoids tapering: a retrospective study.
Rheumatol Int
; 41(3): 611-616, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486552
7.
Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD.
Ann Rheum Dis
; 79(7): 867-873, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32317314
8.
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
Cochrane Database Syst Rev
; 5: CD010455, 2019 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125448
9.
A multi-biomarker score measuring disease activity in rheumatoid arthritis patients tapering adalimumab or etanercept: predictive value for clinical and radiographic outcomes.
Rheumatology (Oxford)
; 56(6): 973-980, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28339738
10.
Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care: analyses of the DRESS study.
Ann Rheum Dis
; 75(11): 1939-1944, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26764260
11.
Seasonal influence on incidence of polymyalgia rheumatica: winter might be coming.
Clin Exp Rheumatol
; 39 Suppl 128(1): 19-20, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634778
12.
Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key.
Ann Rheum Dis
; 78(1): 141-142, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30150367
13.
Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
Cochrane Database Syst Rev
; (9): CD010455, 2014 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25264908
14.
Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial.
RMD Open
; 10(2)2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599654
15.
Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study.
Ann Rheum Dis
; 72(11): 1800-5, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23178206
16.
Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study.
BMC Musculoskelet Disord
; 14: 299, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24152421
17.
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial.
Lancet Rheumatol
; 5(4): e208-e214, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38251523
18.
Non-Medical Switching from Tocilizumab to Sarilumab in Rheumatoid Arthritis Patients with Low Disease Activity, an Observational Study.
Clin Pharmacol Ther
; 114(4): 810-814, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429827
19.
Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study.
Ann Rheum Dis
; 71(11): 1849-54, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22504561
20.
Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study.
BMC Musculoskelet Disord
; 13: 184, 2012 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23006627